Skip to main content
. 2013 Mar 23;13:267. doi: 10.1186/1471-2458-13-267

Table 4.

Changes in health screening variables by medication

Variables Medication group (n = 97) No medication group (n = 103) p valuea
Physical examination
 
 
 
Body weight (kg)
+0.3 (-1.2, +1.6)
+0.8 (-0.8, +2.9)
n.s.
BMI (kg/m2)
+0.2 (-0.6, +0.7)
+0.3 (-0.4, +0.9)
n.s.
Waist circumference (cm)
+1.5 (-2.0, +4.5)
+1.5 (-2.1, +3.2)
n.s.
Systolic blood pressure (mmHg)
+2 (-12, +14)
+4 (-8, +10)
n.s.
Diastolic blood pressure (mmHg)
-2 (-8, +4)
0 (-7, +6)
n.s.
Laboratory examination
 
 
 
HbA1c (%)
+0.2 (0.0, +0.4)
+0.2 (+0.1, +0.3)
n.s.
HDL cholesterol (mmol/L)
-0.05 (-0.18, +0.10)
-0.03 (-0.10, +0.13)
0.009
LDL cholesterol (mmol/L)
-0.05 (-0.31, +0.28)
+0.01 (-0.31, +0.24)
n.s.
Triglyceride (mmol/L)
+0.03 (-0.49, +0.65)
+0.03 (-0.46, +0.44)
n.s.
Treatment status
 
 
 
Periodic clinic visit, new
28 (28.9)
1 (1.0)
<0.001
Periodic clinic visit, discontinuation 0 (0.0) 7 (6.8) 0.009

The alterations in health screening variables were evaluated with post-quake treatment status. Median of change (interquartile range) or number (percentage) is shown.

n.s., not significant.

aMann-Whitney U or Pearson chi-square tests were performed to compare numerical data or ratio data between the tsunami and radiation groups, respectively.

p < 0.05 and p < 0.01 for paired comparison between pre-quake and post-quake values using Wilcoxon matched-pair signed-rank test (Additional file 5: Table S3).

BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.